FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/14/2024
Back to search
Official data from USPTO
DE MOTU CORDIS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
DE MOTU CORDIS
ST13
US500000079362794Class
5, 9, 10, 42, 44
Filing
79362794
Registration
7416380
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
04/03/2026
Trademark type
Word
Nice classes
5, 9, 10, 42, 44
Filing date
12/20/2022
Registration date
06/18/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/18/2024
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
AU
Examiner
POLLACK, ALISON FRIEDBERG
Law office
L60
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
De Motu Cordis Pty Ltd
Representatives
John Pickerill
Technical classification
Nice Classes
Class 5Class 9Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and substances in the field of emergency medicine for the treatment of anaphylactic reactions and cardiac conditions; pharmaceutical preparations and substances for the treatment of anaphylactic reactions; pharmaceutical preparations and substances for treatment of cardiac conditions; pharmaceutical preparations and substances for treatment of heart diseases; pharmaceutical preparations for the treatment of diabetes; glucose for medical purposes; glucose in the form of pharmaceutical productsnamely glucose pharmaceutical preparation for medical purposes; glucose powder for medical purposes; inhalantsinhalant pharmaceutical preparations for the treatment of anaphylactic reactions and cardiac conditions; drugs to be administered by inhalationinhalant pharmaceutical for the treatment of anaphylactic reactions and cardiac conditions; pharmaceutical preparations to be inhaled for the treatment of anaphylactic reactions and cardiac conditions
Class 9
Downloadable computer software for data collection and managementautomated callinglocation tracking and sharingfor providing informationclinical guidance and medical education and training featuring instruction in medicine for medical and health care purposesfor use in assisting with medical emergencies; downloadable application software for data collection and managementautomated callinglocation tracking and sharingfor providing informationclinical guidance and medical education and training featuring instruction in medicine for medical and health care purposesfor use in assisting with medical emergencies; downloadable application software for use in medical emergenciesfor providing clinical guidancefor providing medical information and for medical education and training purposes featuring instruction in medicine; downloadable application software for providing clinical guidance; downloadable application software providing medical information; downloadable application software for medical education and training purposes featuring instruction in medicineemergency medicine and treatment of life threatening conditions; downloadable global positioning systems (GPS) software for tracking and mapping geospatial data; downloadable electronic publications in the nature of journalsinformation sheetsbrochuresnewslettersinstruction manuals providing medical information; downloadable electronic publications in the nature of journalsinformation sheetsbrochuresnewsletters and instruction manuals in the field of medical education and training
Class 10
Medical apparatus for use in emergency treatment of life threatening conditions; medical devices for use in emergency treatment of life threatening conditions; inhalers for medical usesold empty; medical inhalers sold empty and medical inhaler devices provided empty for administering pharmaceuticals; drug delivery apparatus and devicesinhalers for the treatment of anaphylactic reactions and cardiac conditionssold empty; medical apparatusnamely inhalersfor administering drugs into the lungssold empty; apparatus provided empty used for the inhalation of pharmaceutical preparations; filters for inhalers for medical purposes
Class 42
Medicalclinicalscientific and technological research services and new product design relating thereto in the emergency medicine field; medical and scientific researchconducting clinical trials for others; product design and development of medical emergency treatment solutions; design and development of medical devices; product development; scientific and medical research to develop new products; Software as a Service (SaaS) service featuring non-downloadable software for data collection and managementautomated callinglocation tracking and sharingfor providing informationclinical guidance and medical education and training featuring instruction in medicine for medical and health care purposesfor use in assisting with medical emergencies; provision of online non-downloadable software for data collection and managementautomated callinglocation tracking and sharingfor providing informationclinical guidance and medical education and training featuring instruction in medicine for medical and health care purposesfor use in assisting with medical emergencies; provision of online non-downloadable software for use in assisting with medical emergenciesfor providing clinical guidancefor providing medical informationfor medical and education training purposes featuring instruction in medicine; provision of online non-downloadable software for providing clinical guidance; provision of online non-downloadable software providing medical information; provision of online non-downloadable software for medical education and training purposes featuring instruction in medicine; hosting an online website for the provision of medical information; hosting an online website for the provision of medical education and training services
Class 44
Medical services; emergency medical services; telemedicine services; emergency medical services regarding anaphylactic reactions and cardiac conditions; provision of medical information regarding emergency health care including in relation to anaphylactic reactions and cardiac conditions; health care medical consultancy services; provision of medical information; provision of medical information including regarding anaphylactic reactions and cardiac conditions
Publications
History of USPTO decisions and trademark events.
37 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/27/2024
FIMP
FINAL DISPOSITION PROCESSED
11/27/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/18/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/18/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
06/18/2024
GPNX
NOTIFICATION PROCESSED BY IB
04/16/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/02/2024
PUBO
PUBLISHED FOR OPPOSITION
04/02/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/27/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/27/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/13/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/28/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/14/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/14/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
02/14/2024
RDX3
NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
01/26/2024
RDX1
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
01/26/2024
RRDX
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
01/26/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/24/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/23/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
01/23/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
12/14/2023
GNFR
FINAL REFUSAL E-MAILED
12/14/2023
CNFR
FINAL REFUSAL WRITTEN
12/14/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/29/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/29/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/29/2023
RFNT
REFUSAL PROCESSED BY IB
10/25/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/04/2023
RFRR
REFUSAL PROCESSED BY MPU
10/04/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/23/2023
CNRT
NON-FINAL ACTION WRITTEN
09/22/2023
DOCK
ASSIGNED TO EXAMINER
09/21/2023
MAFR
APPLICATION FILING RECEIPT MAILED
02/21/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/17/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/16/2023
Continuous trademark protection
Get notified about every new filing that threatens DE MOTU CORDIS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.